Molecular and clinical analysis on muscle wasting in patients with spinocerebellar ataxia type 1
暂无分享,去创建一个
Y. Itoyama | H. Konno | K. Abe | M. Tobita | T. Kameya
[1] Y. Itoyama,et al. Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan , 1995, Neurology.
[2] H. Zoghbi,et al. Gametic and somatic tissue–specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1 , 1995, Nature Genetics.
[3] D. Housman. Gain of glutamines, gain of function? , 1995, Nature Genetics.
[4] K. Abe,et al. Dominantly inherited cytoplasmic body myopathy in a Japanese kindred. , 1993, The Tohoku journal of experimental medicine.
[5] Huda Y. Zoghbi,et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.
[6] F. Persichetti,et al. HLA‐linked spinocerebellar ataxia: a clinical and genetic study of large Italian kindreds , 1992, Acta neurologica Scandinavica.
[7] A. Beaudet,et al. Spinocerebellar ataxia: Variable age of onset and linkage to human leukocyte antigen in a large kindred , 1988, Annals of neurology.
[8] J. Schut. HEREDITARY ATAXIA: Clinical Study Through Six Generations , 1950 .
[9] H. Zoghbi,et al. Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.
[10] Harry T. Orr,et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia , 1994, Nature Genetics.